Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
) PhD degree at Ghent University) can apply. Exchange students cannot apply for this scholarship; This program is meant for students at the beginning of their PhD. To a limited extent, PhD students
-
these resources. By using data integration, AI, and international platforms like GBIF and LifeWatch, the project supports taxonomic advancement. This PhD research will develop bioinformatics tools to find type
-
for five years, from November 30, 2023, to November 30, 2028. Under this agreement, UGent and CSC co-finance about 50 new CSC PhD students annually. Students selected through the UGent-CSC preference program
-
life. The successful candidate will work closely with experts in food allergy, neuroimmunology, gut physiology, and computational biology to characterize immune cell responses, construct spatial maps
-
Department: Department of Biomedical Sciences Regime Full-time The University of Antwerp is a dynamic, forward-thinking university. We offer an innovative academic education to more than 20.000
-
Department: Department of Biomedical Sciences Regime Full-time The University of Antwerp is a dynamic, forward-thinking university. We offer an innovative academic education to more than 20.000
-
Department: Department of Bioscience Engineering Regime Full-time Let’s shape the future - University of Antwerp The University of Antwerp is a dynamic, forward-thinking, European university. We
-
Health Sciences is looking for a full-time (100%) doctoral scholarship holder in the field of molecular exercise physiology. Research project The PhD research project is conducted in collaboration with
-
back boundaries and set a course for the future – a future that you can help to shape. A-PECS at the Department of Bioscience Engineering in the Faculty of Science is looking for a full-time (100%) PhD
-
the preparation and defence of a PhD thesis in the field of Medical Sciences. More specific, you will work on the validation of predictive peptide biomarkers to classify non-small cell lung cancer (NSCLC) patients